Casual AI Use Is a Business Risk (Even If the Tool Is Secure)
Freelancers usually start with what seems like the right question: Is this tool safe to use? I get asked that question frequently. It’s reasonable. But it’s also the wrong question to start with or to consider on its own, outside of context. Read moreClaude + Consensus: A Powerful Duo—But Know the Risks Before You Click
What Makes an AI Tool “Safe” for Freelancers?
Freelancers must carefully vet AI tools for privacy and safety, prioritizing data security to protect client information and uphold professional reputation while choosing appropriate options.
Your GenAI-Assisted Workflow: Strategic, Secure, and Client-Ready
Whether you’re embracing artificial intelligence (AI) to stay competitive, streamline your workflow, or fight back against outdated assumptions about tech fluency, the key is this: don’t just use AI—use it well. This guide offers a clear, practical approach to integrating generative AI (GenAI) into your work without losing your voice, your standards, or your client’s
Logging AI Use: A Freelancer’s Guide
Why documentation isn’t optional—and how to do it without breaking your workflow Introduction Artificial Intelligence (AI) is changing the way freelancers work—but if you’re not tracking your AI use, you’re leaving yourself (and your clients) exposed. Whether you’re using AI to summarize clinical literature, generate outlines, or polish drafts, your credibility depends on your ability
The Enormous Carbon Footprint of AI
AI sits squarely in the climate gap. Will the unrestricted pursuit of AI in health care exacerbate health inequities? Although artificial intelligence (AI) has exploded in popular culture with the roll out of new generative AI tools for consumers (eg, chatbots, image and voice generation), AI’s role in health care has emerged in a more
Has AI Changed Your Proposal’s Audience?
[This piece originally appeared in our sister blog, Strategic Grantsmanship, on August 21, 2023.] The first rule of writing? “Write to your audience!” For scientific and medical grant proposals, that audience comprises our human scientist and stakeholder peers. Or does it?